SavedAdd your journal

Journals / Akademik Gastroenteroloji Dergisi / 2013 / Cilt: 12 - Sayı: 2

A patient who developed acute myocardial infarction during pegylated interferon alpha-2a and ribavirin therapy for chronic hepatitis C: A case report

Pegile interferon alfa-2a ve ribavirin ile kronik C hepatiti tedavisi sırasında akut miyokard infarktüsü gelişen hasta: Bir olgu sunumu

Nezih PİŞKİNPAŞA
YAŞAR SERTBAŞ
Emin PİŞKİNPAŞA
Pages
84–85
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe his acute myocardial infarction was a serious side effect.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We present the case of a 60-year-old male patient who developed acute myocardial infarction while undergoing pegylated interferon al- pha-2a and ribavirin therapy for chronic C hepatitis.
📊
Key Findings & Data:After two months of therapy, the patient experienced acute anterior myocardial infarc - tion.
💡
Conclusion & Impact:We believe his acute myocardial infarction was a serious side effect.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We present the case of a 60-year-old male patient who developed acute myocardial infarction while undergoing pegylated interferon al- pha-2a and ribavirin therapy for chronic C hepatitis. After two months of therapy, the patient experienced acute anterior myocardial infarc - tion. No ischemic heart disease was diagnosed by cardiologic examina - tions one month before the initiation of the therapy. We believe his acute myocardial infarction was a serious side effect.

Özet

Kronik C hepatitinin pegile interferon alfa-2a ve ribavirin ile tedavi edi- limesi sırasında akut miyokard infarktüsü gelişen 60 yaşındaki bir erkek hastayı sunuyoruz. Hasta, tedaviye başlandıktan iki ay sonra akut an - terior miyokard infarktüsü geçirdi.Tedavinin bir ay öncesinde yapılan kardiyolojik tetkiklerde iskemik kalp hastalığı tespit edilememişti. Akut miyokard infarktüsünün ciddi bir yan etki olduğunu düşündük.

🔖

Cite This Article

PİŞKİNPAŞA, N., SERTBAŞ, Y., PİŞKİNPAŞA, E. (2013). A patient who developed acute myocardial infarction during pegylated interferon alpha-2a and ribavirin therapy for chronic hepatitis C: A case report. Akademik Gastroenteroloji Dergisi, Cilt: 12 - Sayı: 2, 84–85. https://ajindex.com/articles/356824

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ökten A, Demir K, Kaymakoğlu S, et al. Kronik hepatitlerin etyolojik dağılımı. Turk J Gastroenterol 1998; 2: 113-5
  2. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Eng J Med 2002; 347: 975-82
  3. Di Bisceglia AM, McHUtchison J, Rice CM. New therapeutic strate - gies for hepatitis C. Hepatology 2002; 35: 224-31
  4. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa 2b plus ribavirin compared with interferon alfa 2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized study. Lancet 2001; 358: 958-65
  5. Fried MW. Side effects of therapy of hepatitis C and their manage - ment. Hepatology 2002; 36: 237-44
  6. McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for initial treatment of chronic hepatitis C. Semin Liver Dis 1999; 19(Suppl 1): 57-65
  7. Kumar V, Cotran SR, Robbins SL.Temel Patoloji. In.:Çevikbaş U, ed. 6 th ed. İstanbul. Nobel Tıp Kitapevi 2000; 283-9
  8. Pocok SJ, Shaper G, Phillips AN. Concentrations of high density lipoprotein cholesterol, triglyserides and total cholestherol in isch- aemic heart disease. Br Med J 1989:298:998-1002
  9. Graystone JT, Kuo CC, Wang SP, et al.A new chlamydia psittaci strein, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8
  10. Teragawa H, Hondo T, Amano H, et al. Adverse effects of interfer- on on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J 1996; 37: 905-15
  11. Rechcinski T, Matusik D, Rudzinski D, et al. Exacerbation of atrio- ventricular block during treatment of hepatitis C with peginterfer- on. Polskie Archiwum Medycyny Wewnetrznej 2007; 1: 1-3
  12. Hoofnagle JH, Seff LB. Peginterferon and chronic hepatitis C. N Engl J Med 2006;355:2444-51
  13. Sonnenblick M, Rosin A. Cardiotoxicity of interferon. A review of 44 cases. Chest 1991; 3: 557-61
  14. Forde KA, Haynes K, Troxel AB, et al. Risk of myocardial infarction associated with chronic hepatitis C virus infection. J Viral Hepat 2012;19:271-7.